NCT02822495 2023-06-15Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or MalignanciesAtara BiotherapeuticsNo longer available
NCT00547235 2010-08-24Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV InfectionFred Hutchinson Cancer CenterNo longer available